Search
for
Sort by
Research 931–960 of 1000+
- Decreased CD200R expression on monocyte-derived macrophages correlates with Th17/Treg imbalance and disease activity in rheumatoid arthritis patients
- Role of β-Catenin Activation Levels and Fluctuations in Controlling Cell Fate
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
- Regulation of pathophysiological and tissue regenerative functions of MSCs mediated via the WNT signaling pathway (Review)
- Basal Cell Carcinoma, Hedgehog Signaling, and Targeted Therapeutics: The Long and Winding Road
- Promoting axonal regeneration through exosomes: An update of recent findings on exosomal PTEN and mTOR modifiers
- Targets to treat androgen excess in polycystic ovary syndrome
- Regulation of Semaphorin3A in the process of cutaneous wound healing
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Polymeric micelle mediated follicular delivery of spironolactone: Targeting the mineralocorticoid receptor to prevent glucocorticoid-induced activation and delayed cutaneous wound healing
- Adrenal steroid precursors exert potent androgenic action in the hamster sebaceous glands of flank organs and ears.
- Differential effects of Wnt5a on the proliferation, differentiation and inflammatory response of keratinocytes
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Causality of Aging Hallmarks
- Co-opting Developmental Signaling Pathways to Promote Wound Healing
- The role of protein lactylation in skin diseases: from molecular mechanisms to potential therapeutics
- Management of Hirsutism and Acne in Women with Polycystic Ovary Syndrome: A Narrative Review of Current Evidence and Emerging Therapies
- Epithelial–mesenchymal transition in cutaneous fibrosis disease: from mechanisms to therapy
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- LOCAL IRRITANT AND SKIN RESORBING EFFECT OF ZINC HYDROCARBONATE NANOPARTICLES STABILIZED BY POLYVINYLPYRROLIDONE
- Skin aging: mechanisms, evaluation, and rejuvenation
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- GPCRs as key regulators in wound healing
- SPT6 maintains epidermal homeostasis by inhibiting an NF-κB-positive feedback loop to prevent excessive inflammation
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- The orchestrated network of skin photoaging: From intercellular crosstalk to molecular signaling
- Radiotherapy-Induced Skin Fibrosis: Pathophysiology, Emerging Therapeutics, and the Role of Dermatology